I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

Recruiting

I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

Sponsor:

Miami Cancer Research Center, Inc.

Code:

NCT06443866

Conditions

Thyroid Cancer

RAI-Refractory Thyroid Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Disease status detection

Theranostic dosimetry

I-124 PET/CT imaging

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-12. This information was provided to ClinicalTrials.gov by Miami Cancer Research Center, Inc. on 2024-06-05.